Stifel Maintains Buy on Celcuity, Raises Price Target to $125
3/26/2026
Impact: 75
Healthcare
Stifel analyst Stephen Willey has reiterated a Buy rating on Celcuity (NASDAQ: CELC) and increased the price target from $115 to $125. This adjustment reflects a positive outlook for the company's performance.
AI summary, not financial advice
Share: